ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AB06 | BioTech | Golimumab - 100mg/1ml | 10281/945 | 23220/1 | SIMPONI | 100mg/1ml | 1 | Injectable solution | SC | Abela Frères S.A.L. | Cilag AG | Switzerland | 83,360,986 L.L | 2.44 | E2 | Janssen Biologics BV | The Netherlands | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AB06 | BioTech | Golimumab - 100mg/1ml | 10281 | 23220/1 | SIMPONI | 100mg/1ml | 1 | Injectable solution | SC | Abela Frères S.A.L. | Cilag AG | Switzerland | 1,367,323 L.L | 2.44 | E2 | Janssen Biologics BV | The Netherlands | 2/5/2024 |